- Olodanrigan
-
- $35.00 / 5mg
-
2026-04-21
- CAS:1316755-16-4
- Min. Order:
- Purity: 98.33%
- Supply Ability: 10g
- PD-126055 free acid
-
- $1.00 / 1kg
-
2019-07-06
- CAS:1316755-16-4
- Min. Order: 1kg
- Purity: 95%-99%
- Supply Ability: 100kg
|
| | PD-126055 free acid Basic information |
| Product Name: | PD-126055 free acid | | Synonyms: | PD-126055 free acid;EMA401;(3S)-2-(2,2-Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinolinecarboxylic acid;Olodanrigan(EMA401);CS-2652;Olodanrigan;(S)-5-(benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;OLODANRIGAN;EMA 401;EMA-401;EMA401 | | CAS: | 1316755-16-4 | | MF: | C32H29NO5 | | MW: | 507.58 | | EINECS: | | | Product Categories: | API | | Mol File: | 1316755-16-4.mol |  |
| | PD-126055 free acid Chemical Properties |
| Boiling point | 745.3±60.0 °C(Predicted) | | density | 1.256±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | DMSO:20.0(Max Conc. mg/mL);39.4(Max Conc. mM) | | pka | 3.54±0.20(Predicted) | | form | A crystalline solid | | color | White to off-white | | InChIKey | GHBCIXGRCZIPNQ-MHZLTWQESA-N | | SMILES | C1C2=C(C(OCC3=CC=CC=C3)=C(OC)C=C2)C[C@@H](C(O)=O)N1C(C(C1=CC=CC=C1)C1=CC=CC=C1)=O |
| | PD-126055 free acid Usage And Synthesis |
| Uses | Olodanrigan is an intermediate used in the prepation of enantiopure angiotensin II type 2 receptor [AT2R] antagonist EMA401. | | in vivo | EMA401 (10mg/kg; p.o.) results in a significant attenuation of theta power and increase in paw withdrawal latencies (PWL) in rats at day 14 after chronic constriction injury (CCI)[4]. | | IC 50 | AT2 Receptor |
| | PD-126055 free acid Preparation Products And Raw materials |
|